Selective Activation of G Protein Subtypes in the Vomeronasal Organ upon Stimulation with Urine-derived Compounds*

Jürgen KriegerDagger , Annette SchmittDagger , Diedrich LöbelDagger , Thomas Gudermann§, Günter Schultz§, Heinz BreerDagger , and Ingrid BoekhoffDagger

From the Dagger  Universität Stuttgart-Hohenheim, Institut für Physiologie, Garbenstr. 30, 70593 Stuttgart, Germany and the § Freie Universität Berlin, Institut für Pharmakologie, Thielallee 69-73, 14195 Berlin, Germany

    ABSTRACT
Top
Abstract
Introduction
References

Chemosensory neurons in the vomeronasal organ (VNO) detect pheromones related to social and reproductive behavior in most terrestrial vertebrates. Current evidence indicate that the chemoelectrical transduction process is mediated by G protein-coupled second messenger cascades. In the present study, attempts were made to identify the G protein subtypes which are activated upon stimulation with urinary pheromonal components. G protein-specific antibodies were employed to interfere specifically with inositol 1,3,4-trisphosphate formation induced by urinary stimuli and to immunoprecipitate Galpha -subunits, activation dependently labeled with [alpha -32P]GTP azidoanilide. The results of both experimental approaches indicate that stimulation of female VNO membrane preparations with male urine samples induces activation of Gi as well as Go subtypes. Experiments using different fractions of urine revealed that upon stimulation with lipophilic volatile odorants, only Gi proteins were activated, whereas Go activation was elicited by alpha 2u-globulin, a major urinary protein, which is a member of the lipocalin superfamily. Since each G protein subtype is stereotypically coexpressed with one of the two structurally different candidate pheromone receptors (V1R and V2R), the results provide the first experimental evidence that V1Rs coexpressed with Gi may be activated by lipophilic probably volatile odorants, whereas V2Rs coexpressed with Go seem to be specialized to interact with pheromonal components of proteinaceous nature.

    INTRODUCTION
Top
Abstract
Introduction
References

Terrestrial vertebrates detect chemical signals via sensory neurons located in two anatomically distinct systems: the nasal olfactory epithelium (OE)1 and the vomeronasal organ (VNO). Whereas the main olfactory system is responsible for the "conventional" sense of smell, the VNO appears to specifically detect pheromones, thereby inducing a distinct social or sexual behavior or endocrine response (1-3). In rodents, the major source of phermones seems to be the urine, however, only few volatile (4) and non-volatile (5) urinary substances producing a definite endocrine or behavioral response have been identified. The best characterized non-volatile urinary components in male mouse urine are the "major urinary proteins" (6). Major urinary proteins have been suggested to be involved in puberty acceleration (5, 7, 8), an endocrinological effect prevented by lesions of the VNO or the accessory olfactory bulb (1). Major urinary proteins of mice and the rat equivalent alpha 2u-globulin (9) belong to the superfamily of lipocalins, a structurally homologous but diverse family of extracellular proteins, characterized by their ability to bind small, principally hydrophobic molecules (10). Although recent structural studies have characterized the naturally bound volatile substances (11), major urinary proteins lacking the natural volatiles remain active (8) suggesting that proteins themselves act as pheromones.

The molecular mechanisms responsible for the detection of pheromones and the signal transduction processes in the VNO are not well understood. Initially, it has been suggested that the transduction mechanisms in the VNO would resemble those in the olfactory epithelium, but some of the specific molecular components involved in the transduction of odorants in receptor neurons of the OE, like Golf, adenylyl cylase (AC) subtype III, and the alpha -subunit of the cyclic nucleotide-gated cation channel could not be detected in the neuroepithelium of the VNO (12, 13). Moreover, recent molecular biology advances implicate that neurons in the VNO utilize another set of receptor genes than the olfactory epithelium. Two novel and structurally unrelated multigene families of putative pheromone receptors have been identified (V1R and V2R) which are exclusively expressed in neurons of the VNO (14-17). Although receptors of both families represent members of G protein-coupled receptors, the structural differences especially in the N-terminal region led to the concept that each receptor family may be tuned to recognize a distinct class of ligands.

Receptors of each family show a distinct nonoverlapping expression pattern within two major laminar zones. Whereas V1Rs are expressed in the apical half of the neuroepithelium, V2Rs are restricted to the basal region of the epithelium. An identical spatial expression pattern has also been observed for two types of G protein alpha -subunits. Whereas Gi is expressed only in apical neurons, Go expression is restricted to neurons in the basal half of the VNO neuroepithelium (13, 14, 18). The stereotypical distribution of both receptor families with distinct G protein subtypes implies a linkage between both components.

The present study was aimed to characterize the G protein subtypes in the rat vomeronasal organ activated upon stimulation with male urine by performing photoaffinity labeling experiments. Furthermore, antibodies for different G protein subtypes were employed to interfere with the urine-induced IP3 signaling. To evaluate whether there is any correlation between the chemical properties of applied urinary stimuli and the activation of distinct G protein subtypes, stimulation experiments were performed with different fractions of urine as well as with purified alpha 2u-globulin.

    EXPERIMENTAL PROCEDURES

Materials

Male and female adult Sprague-Dawley rats were purchased from Charles River, Sulzfeld, Germany. The odorant menthone was provided by DROM (Baierbrunn, Germany), amyl acetate was purchased from Sigma (Deisenhofen, Germany). Hydroxyapatite Type I was obtained from Bio-Rad (München, Germany), the Centricon concentrators were purchased from Millipore (Eschborn, Germany), enterokinase was from Boehringer (Mannheim, Germany). The radioligand assay kits for cAMP (adenosine 3',5'-cyclic phosphate) and myo-[3H]inositol 1,4,5-trisphosphate determination were provided by Amersham; [alpha -32P]GTP was purchased from NEN Life Science Products Inc. Sources of other materials have been described (19).

Methods

Antisera-- Antisera against G protein subunits were obtained after injection of synthetic peptides representing subtype-specific regions of different subunits into rabbits as described previously (20) or provided by Santa Cruz Biotechnology, Santa Cruz, CA. The peptide sequences used to raise the antisera are shown in Table I.

Urine Collection and Purification-- Urine from male fertile rats (12-14 weeks old) was collected daily, pooled, centrifuged to remove cells (5 min, 5, 500 × g), and stored as aliquots at -70 °C until use. To extract hydrophobic volatile odorants, a 2-ml volume of pooled male urine was treated with 2 ml of dichloromethane; following separation of the organic and water phase by centrifugation (10 min, 6,000 × g), both phases were collected and stored at -70 °C.

Purification of alpha 2u-Globulin-- Urine was collected from fertile male rats, pooled, and stored immediately at -70 °C. After thawing to 4 °C, a 50-ml pool was centrifuged at 5,000 × g for 30 min at 4 °C, and the clear urine was dialyzed against 4 mM sodium phosphate buffer, pH 6.8. The purification of alpha 2u-globulin was performed according to Holmquist et al. (21). Briefly, after addition of phenylmethylsulfonyl fluoride to a final concentration of 0.1 mM, the samples were applied to a 1.5 × 10-cm hydroxyapatite column with a flow rate of 0.5 ml/min. The column was washed with 10 times column volumes of 4 mM sodium phosphate buffer, pH 6.8. Elution was performed using a linear 4-400 mM sodium phosphate buffer gradient, pH 8.0. Total protein was evaluated by monitoring the A280, corresponding fractions were pooled and analyzed by SDS-PAGE. Fractions containing the 18-kDa proteins were collected, dialyzed against reaction buffer (200 mM NaCl, 10 mM EGTA, 50 mM Mops, 2.5 mM MgCl2, 1 mM dithiothreitol, 0.05% sodium cholate, 1 mM ATP, and 4 µM GTP, 12 nM CaCl2, pH 7.4) and concentrated using Centricon-10 to a final protein concentration of 17 mg/ml.

Construction of Expression Plasmids-- DNA-related methods were performed according to standard procedures (22). The coding sequences of alpha 2u-globulins were amplified by polymerase chain reaction using cDNA obtained by reverse transcription of poly(A)+ RNA from male rat liver. A recombinant alpha 2u-globulin with an N-terminal sequence corresponding to the endogenous protein was generated by using an extended 5'-oligonucleotide in the polymerase chain reaction that contained a BamHI site (underlined) and the sequence coding for an enterokinase cleavage site in-frame to the coding sequence: alpha 2u-forward 5'-ggatccgtacgacgatgacgataaggaagaagctagttccacaagagg-3'; as an antisense primer oligonucleotide containing an HindIII site (underlined), the following oligonucleotide was used: alpha 2u-reverse 5'-aaagcttcgtcaac-ctcaggcctggagacagcg-3'. The amplification products were cloned into the pGEM-T vector. All derived plasmid constructs were confirmed by DNA sequencing. For subcloning into the expression vector pTrcHis, the alpha 2u-globulin sequences from pGEM-T-plasmids were cut out with BamHI and HindIII restriction enzymes and ligated in-frame into the corresponding vector sites. The expression constructs were transformed into Escherichia coli BL21 (DE3).

Growth of Cells and Protein Purification-- 100 ml of LB-medium with ampicillin (100 µg/ml) was inoculated with an overnight culture in the same medium and grown at 37 °C. Protein expression was induced at A600 of 0.5-0.7 with 0.2 mM isopropyl-beta -D-thiogalactoside, and growth was continued for 3 h. Cells were harvested by centrifugation at 2,000 × g for 15 min and resuspended in 20 ml of 50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, 20 mM imidazole, 0.25 mg/ml lysozyme, and 1 mM phenylmethylsulfonyl fluoride and stored on ice for 1 h. For damage of spheroplastes, cells were frozen in liquid nitrogen and thawed at room temperature. After sonification with a tip sonicator for 2 min on ice, the soluble material was separated from cell debris and inclusion bodies by centrifugation at 30,000 × g for 30 min. The supernatant was collected and used for affinity chromatography.

For purification of His-tagged proteins, the cytosol was loaded onto a Ni-NTA agarose column equilibrated against washing buffer (50 mM sodium phosphate buffer, pH 8.0, 300 mM NaCl, and 20 mM imidazole) and washed with 5 column volumes of washing buffer. Subsequently, bound protein was eluted as single peak by increasing the concentration of imidazole to 250 mM. Fractions of 1 ml were collected and protein concentrations were monitored by A280; corresponding fractions were pooled and dialyzed twice for 8 h against 50 mM Tris/HCl, pH 7.5.

Protein concentration was adjusted to 1 mg/ml with 50 mM Tris/HCl, pH 7.5, 0.1% Tween 20. Cleavage of fusion protein was performed by incubation with 1/40 (w/w) enterokinase for 16 h at 37 °C. Subsequently, the NaCl concentration was increased to a final concentration of 500 mM, and agarose-coupled soybean trypsin inhibitor was added; after an incubation for 2 h at 4 °C, soybean trypsin inhibitor bound enterokinase was precipitated by centrifugation (2,000 × g for 10 min) and the supernatant was recovered.

Preparation of Vomeronasal Organ Membranes-- Membrane fractions of the VNO were prepared as described previously (23). Briefly, VNOs removed from fertile male rats were washed twice in Ringer's solution (120 mM NaCl, 5 mM KCl, 1.6 mM K2HPO, 25 mM NaHCO3, 7.5 mM glucose, pH 7.4) to remove superficial blood and debris and subsequently frozen in liqiud nitrogen. Each pooled sample (30-60 animals) was thawed on ice, minced, and subsequently subjected to Ringer's solution containing 10 mM calcium chloride; after gently stirring for 10 min at 4 °C, debris was removed by centrifugation (10 min, 3,000 × g), the resulting supernatant was collected and the pellet was resuspended again in Ringer's solution containing CaCl2 as described above. The pooled supernatants containing the membrane fractions were centrifuged again for 30 min at 48,000 × g and the resulting pellet was resuspended in aliquots (100-500 µg in 500 µl) in hypotonic buffer (10 mM Tris/HCl, 3 mM MgCl2, 2 mM EGTA, pH 7.4) and stored at -70 °C. Olfactory cilia of the OE were obtained using the calcium-shock method as described previously (24).

Stimulation Experiments and Second Messenger Determination-- Stimulation experiments, performed with male rat urine, separated fractions of urine, isolated alpha 2u-globulin of male urine, and recombinant alpha 2u-globulin were performed as described previously (24).

Briefly, 300 µl of reaction buffer (200 mM NaCl, 10 mM EGTA, 50 mM Mops, 2.5 mM MgCl2, 1 mM dithiothreitol, 0.05% sodium cholate, 1 mM ATP, and 4 µM GTP, pH 7.4) including 12 nM free calcium calculated and adjusted as described (25), was prewarmed at 37 °C with or without odorants. The reaction was started by the addition of 60 µl of VNO membrane preparations, incubated for 2 min at 37 °C and stopped by 7% ice-cold perchloric acid (200 µl) before the concentration of IP3 was determined according to Palmer et al. (26). To prevent degradation of IP3, stimulation experiments were performed in the presence of 10 mM LiCl (final concentration during incubation). To determine the influence of the subtype-specific G protein alpha -subunit antisera on the efficiency of urine-induced second messenger responses, membrane preparations of the VNO were preincubated with the indicated dilutions of the specific antisera and subsequently stimulated with urine or purified fractions of urine.

Photolabeling of Activated G Proteins-- [alpha -32P]GTP azidoanilide was synthesized and purified as described (27); receptor-dependent G protein labeling was performed as described previously (20). Briefly, frozen VNO membrane preparations in hypotonic buffer were centrifuged (10 min, 12,000 × g, 4 °C) and resuspended in double concentrated labeling buffer (60 mM HEPES, 5 mM MgCl2, 200 mM NaCl, 200 µM EDTA, 500 µM GDP, pH 7.4). 10 µl of urine, general odorants, separated urine fractions (diluted in water), or alpha 2u-globulin (diluted in reaction buffer) were adapted to 37 °C with 20 µl of [alpha -32-P]GTP azidoanilide (4 × 106 cpm/tube). The reaction was started by adding 30 µl of VNO membrane preparations (1-2 µg/µl); after an incubation period of 2 min at 37 °C the reaction was terminated by cooling the samples to 4 °C. Excess [alpha -32P]GTP azidoanilide was removed by centrifugation (5 min, 12,000 × g, 4 °C). The pellet was resuspended in labeling buffer containing 2 mM dithiothreitol, placed on a Parafilm-coated metal plate (4 °C), and irradiated for 30 s with a 254-nm UV lamp (150 W, Vl-100 Grid-Tube, Herolab GmbH).

Immunoprecipitation-- Photolabeled membranes were pelleted and solubilized in 2% (w/v) SDS for 10 min at room temperature before 20 µl/tube of precipitation buffer (10 mM Tris/HCl, 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride, 1% desoxycholate, 1% Tergitol Nonidet P-40, 10 µg/ml aprotinin, pH 7.4) and 5 µl/tube of the indicated, undiluted subtype-specific G protein alpha -subunit antisera were added.

After 1 h at 4 °C under constant rotation, 60 µl of Protein A-Sepharose (3 mg) was added and the samples were incubated overnight at 4 °C. Thereafter the Sepharose beads were pelleted (1 min, 12,000 × g, 4 °C) and washed twice with 1 ml of washing buffer A (50 mM Tris/HCl, 600 mM NaCl, 0.5% SDS, 1% Tergitol Nonidet P-40, pH 7.4) and twice with washing buffer B (100 mM Tris/HCl, 300 mM NaCl, 10 mM EDTA, pH 7.4). Preparation of the samples for SDS-PAGE was performed as described Laugwitz et al. (20). Incorporated [alpha -32P]GTP azidoanilide was determined densitometrically after gel-exposure to a PhosphorImager (Fuji).

    RESULTS

Based on a recent study indicating that treatment of vomeronasal organ slice preparations of rats with urine dilutions elicit an increased impulse frequency of sensory neurons which can be blocked by phospholipase C inhibitors (28), we set out to explore whether urine-induced IP3 responses in membrane preparations of VNOs from female rat are mediated by a G protein-controlled reaction cascade. IP3 responses induced upon stimulation with different concentrations of male urine (0.1 to 4%, v/v) were determined in the presence of GTP or GDP. The results in Fig. 1 demonstrate that male urine elicited a dose-dependent increase in the formation of IP3; this response was only observed in the presence of GTP indicating that urine-induced phospholipase C activation in the VNO is mediated via G proteins.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 1.   GTP dependence of the production of IP3 induced upon stimulation with different dilutions of male rat urine. Membrane preparations of VNOs of female rats were stimulated with different dilutions of male rat urine ranging from 0.1 to 4% (v/v), either in the presence of 4 µM GTP or alternatively in the presence of 10 µM GDP. Data are calculated as urine-induced IP3 formation. Basal level of IP3 was 33.9 ± 12.9 pmol/mg of protein. Values are the means of three independent experiments ± S.D.

Immunohistochemical studies (18, 29, 30) and in situ hybridization experiments (13) have demonstrated that different G proteins alpha -subunits (Gs, Gi2, Go, and Gq/11/13) are expressed in neurons of the VNO. Toward an identification of distinct G protein subtypes which are activated upon stimulation with urine, a photoaffinity labeling approach was employed using the photoreactive, hydrolysis resistant [alpha -32P]GTP azidoanilide (27, 20). Female VNO membrane preparations were stimulated with two different concentrations of male urine in the presence of [alpha -32P]GTP azidoanilide, and subsequently distinct G protein alpha -subunits were immunoprecipitated (24) using subtype-specific antibodies for different G protein alpha -subtypes (Table I).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Peptide sequences used for generation of antibodies
(C) indicates that a N-terminal cysteine was added to the original peptide sequence in order to facilitate coupling to keyhold limpet hemocyanin.

Fig. 2 shows that urine addition significantly enhanced incorporation of [alpha -32P]GTP azidoanilide into Galpha i as well as Galpha o subtypes. Quantification of the labeling intensity indicates that stimulation with male urine (0.2%, v/v) induced a 57% increase in Galpha i labeling and a nearly 100% increase in the [alpha -32P]GTP azidoanilide incorporation into Galpha o compared with control samples. In contrast, proteins precipitated with an antiserum specific for Galpha s and Galpha olf (AS 348) as well as Galpha q subtypes (AS 368) show only very weak incorporation of [alpha -32P]GTP azidoanilide under control conditions, and no increase upon urine stimulation was registered (data not shown).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Effect of different concentrations of male rat urine on photoaffinity labeling of Galpha i and Galpha o. Vomeronasal organ preparations of female rat were photolabeled in the absence (control) or presence of two different concentrations of male rat urine indicated in percent v/v. Labeled membranes were solubilized, and immunoprecipitations were performed using either the antibody C-10, specific for Galpha i (top panel), or the selective Galpha o antibody K-20 (bottom panel). The autoradiograms, showing the 40-kDa regions of a SDS-PAGE, are representative of three independent experiments each giving very similar results. The intensity of labeling, represented as photostimulated luminescence (PSL), was determined densitometrically. Data were calculated as percentage of the basal photostimulated luminescence obtained in the absence of urine.

Antibodies for distinct G protein alpha -subtypes have been successfully used to selectively inhibit ligand-induced phosphatidylinositol bisphosphate hydrolysis (24, 31). Accordingly, membrane preparations of female VNOs from rat were pretreated with different concentrations of subtype-specific antibodies and subsequently stimulated with a 2% (v/v) dilution of male urine. As demonstrated in Fig. 3A, preincubation with the Galpha i common antibody C-10 or with the Galpha o-specific antibody K-20 attenuated the urine-induced IP3 response in a concentration-dependent manner; 50% inhibition was obtained at a 1:500 dilution of either antibody. In contrast, antibody AS 348 specific for Galpha s subtypes as well as AS 368 selective for the Galpha q subfamily did not affect the responsiveness significantly (Fig. 3B). These results indicate that the IP3 response in female VNO preparations induced upon stimulation with a complex pheromonal mixture (male urine) is mediated via Gi as well as Go proteins.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 3.   Concentration-dependent inhibition of urine-induced IP3 formation by different Galpha subtype-specific antibodies. Aliquots of membrane preparations of female VNOs were pretreated with different concentrations of Galpha subtype-specific antibodies (A, C-10 for Galpha i and K-20 for Galpha o; B, AS-368 for Galpha q and AS-348 for Galpha s) and subsequently samples were stimulated with a 2% (v/v) dilution of male rat urine. The basal level of IP3 in the VNO preparations under control conditions (38.1 ± 6.8 pmol/mg of protein) was not affected upon pretreatment with the different G protein antibodies. The data are calculated as percent of urine-induced IP3 formation (57.9 ± 13.0 pmol/mg of protein). Values are the means of three experiments ± S.D.

Functional and chemical analysis of urine from rodents have shown that pheromonal components are found in both the volatile as well as non-volatile fraction (5, 32). The volatile components can be extracted from whole male urine using dichloromethane (8). Using this procedure, the dichloromethane-extractable urinary components as well as the remaining aqueous fraction were subsequently analyzed for their ability to induce IP3 responses in VNO membrane preparations. As shown in Fig. 4, compounds extracted with dichloromethane induced a concentration-dependent increase in the level of IP3, indicating that this fraction contained active ligands; in contrast, the aqueous fraction did not induce any changes in the concentration of IP3 compared with control samples (Fig. 4). Although it is unclear why the aqueous fraction is inactive it is conceivable that the proteins may be denaturated by dichloromethane.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Dose-response curve of IP3 formation induced upon stimulation with urinary fractions. Different concentrations of organic urinary substances of male rat urine extracted with dichloromethane or the remaining aqueous urinary components were applied to VNO membrane preparations. Basal levels of IP3 obtained upon incubating of VNO preparations only with reaction buffer were 24.03 ± 7.3 pmol/mg of protein; treatment of samples with a 5% (v/v) dilution of pure dichloromethane did not affect the concentration of IP3 (26.0 ± 4.8 pmol/mg of protein). Data are presented as ligand-induced IP3 concentration in picomole/mg of protein and are the mean values of three experiments ± S.D.

In order to address the issue of which G protein subtypes are labeled upon stimulation with the volatile urinary components, additional photoaffinity labeling experiments were performed employing different concentrations of the dichloromethane extract (0.02-0.4%, v/v). As demonstrated in Fig. 5, the organic extract induced a dose-dependent incorporation of [alpha -32P]GTP azidoanilide into Galpha i, whereas a stimulus-induced labeling of Galpha o was not detectable (Fig. 5). These results indicate that Gi proteins but not Go proteins are activated upon stimulation with volatile urinary components.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of increasing concentrations of an organic extract of male rat urine on photolabeling of Galpha i and Galpha o. Membrane preparations of VNOs of female rats were stimulated with different concentrations of a dichloromethane extract of male rat urine ranging from 0.0 to 0.4% (v/v) (indicated as numbers) in the presence of [alpha -32P]GTP azidoanilide. Galpha i was precipitated with the antibody AS 266 (top panel), whereas Galpha o was precipitated with the antibody K-20 (bottom panel). The autoradiograms showing the 40-kDa region of a SDS-PAGE are representative of three independent experiments with similar results. Quantification of incorporated [alpha -32P]GTP azidoanilide was determined by densitometric analysis of autoradiograms presented as photostimulated luminescence (PSL) and calculated as percentage of the basal photolabeling obtained in the presence of 0.4% (v/v) dichloromethane.

To confirm this observation, the effects of Galpha i as well as Galpha o antibodies on dichloromethane extract-induced IP3 signaling were analyzed. VNO preparations were pretreated with different concentrations of each of the two subtype-specific antibodies and subsequently stimulated with a 2% (v/v) dilution of the organic urinary extract. Whereas the dichloromethane extract induced IP3 formation was only slightly affected upon pretreatment with high concentrations of the Galpha o antibody (1:250 dilution), Galpha i antibodies caused already a strong inhibition at very low antibody concentrations: at a 1:2000 dilution of the Galpha i antibody, the dichloromethane extract-induced IP3 response was blocked by 70% (Fig. 6).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of subtype-specific antibodies for different G proteins on IP3 formation induced upon stimulation with an organic urinary extract. Membrane preparations of female rat VNOs were incubated with different concentrations of Galpha i (C-10) as well as Galpha o (K-20) specific antibodies and subsequently stimulated with a 2% (v/v) dilution of the urinary dichloromethane extract. Data are calculated as percent of ligand-induced IP3 formation (54.2 ± 8.6 pmol/mg of protein); the basal level of IP3 was 32.2 ± 13.0 pmol/mg of protein. Data are the means of three independent experiments ± S.D.

Previous electrophysiological experiments have demonstrated that the vertebrate VNO system is not only selective to a narrow range of pheromonal components, but in addition is sensitive to various general odorants normally known to be reorganized by the olfactory epithelium (33). In order to address the question which G protein subtypes are activated upon stimulation with volatile odorants, amyl acetate and menthone, which elicit electrical responses in turtle VNO neurons (33), were applied in photolabeling experiments. Membrane preparations of rat VNOs were stimulated with different concentrations of the two general odorants and subsequently Galpha i as well as Galpha o subtypes were precipitated by means of subtype-specific antibodies. Application of menthone (Fig. 7) as well as amyl acetate (not shown) induced a concentration-dependent labeling of Galpha i, however, neither menthone (Fig. 7) nor amyl acetate (not shown) induced a significant incorporation of the GTP analog into Galpha o.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of menthone on photolabeling of Galpha i and Galpha o. Membrane preparations of female rat VNOs were stimulated with increasing concentrations of the minty odorant menthone (1-100 µM), and subsequently Galpha i (top panel) as well as Galpha o (bottom panel) were immunoprecipitated with subtype-specific antibodies (C-10 for Galpha i; K-20 for Galpha o). The autoradiograms show the 40-kDa region of a SDS-PAGE and are representative of three independent experiments with similar results. The intensity of the photolabeling of Galpha i as well as Galpha o was evaluated densitometrically, data were calculated as percentage of the basal photolabeling obtained in the absence of odorant.

The observation that neither organic components from male urine nor general volatile odorants induced Go activation led to the idea that urinary proteins may be ligand candidates for Go stimulation. In urine of fertile male rats, androgen-dependent alpha 2u-globulin, a member of the lipocalin superfamily (10), is the quantitatively major protein (9). Therefore, alpha 2u-globulin was purified from male urine as described by Holmquist et al. (21) and assessed for its capability to induce IP3 formation. The results of these experiments (Fig. 8) indicate that purified alpha 2u-globulin induced a very strong concentration-dependent increase in the concentration of IP3.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 8.   Tissue specificity of the production of IP3 by alpha -globulin in female VNO preparations. A, concentration-response curves of alpha 2u-globulin-induced IP3 formation. Membrane preparations of female rat VNOs were stimulated with different concentrations of either alpha 2u-globulin purified from male rat urine or recombinant protein expressed in E. coli. Data are calculated as ligand-induced IP3 formation; the basal level in the absence of the lipocalin was 23.6 ± 8.8 pmol/mg of protein. Data are the means of three independent experiments ± S.D. B, effect of recombinant alpha 2u-globulin on IP3 formation in olfactory cilia of the OE. Isolated olfactory cilia were incubated either with reaction buffer (control) or stimulated with recombinant alpha 2u-globulin (50 µM), respectively, the nonhydrolyzable GTP analogue GTPgamma S (1.6 µM), and subsequently the concentration of IP3 was determined.

Since the procedure for isolating native alpha 2u-globulin, such as gel permeation and dialysis purification steps, are not sufficient to separate noncovalently bound volatile urinary compounds (34), recombinant alpha 2u-globulin, heterologously expressed in E. coli, was employed. As shown in Fig. 8A, application of recombinant alpha 2u-globulin also induced an elevated IP3 response; however, the efficacy was considerably smaller compared with native purified urinary protein. Nevertheless, the alpha 2u-globulin-induced second messenger response is specific since stimulation of olfactory cilia from the OE did not show any changes in IP3 concentration (Fig. 8B). To characterize the G protein subtype involved in recombinant alpha 2u-globulin-induced IP3 signaling, the effect of subtype-specific antibodies on IP3 formation was analyzed. As documented in Fig. 9, Galpha i antibodies did not alter the responsiveness to alpha 2u-globulin, even at rather high concentrations. In contrast, antibodies against Galpha o significantly attenuate IP3 formation in a concentration-dependent manner. This observation was confirmed in photoaffinity labeling experiments; stimulating VNO membrane preparations with 1 µM recombinant alpha 2u-globulin led to a significant incorporation of [alpha -32P]GTP azidoanilide into Galpha o, whereas labeling of Galpha i subtypes was not changed (Fig. 10).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 9.   Selective blockade of alpha 2u-globulin induced IP3 formation by Galpha o-specific antibodies. Membrane preparations of female rat VNOs were pretreated for 10 min on ice with different concentrations of Galpha i (C-10) or Galpha o (K-20)-specific antibodies and subsequently stimulated with 50 µM recombinant alpha 2u-globulin. Data are calculated as % of ligand-induced IP3 formation (51.2 ± 5.0 pmol/mg of protein); the basal level of IP3 in the absence of the lipocalin was 31.7 ± 4.7 pmol/mg of protein. Data are the means of three independent experiments ± S.D.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 10.   Photoaffinity labeling of Galpha i and Galpha o subtypes upon stimulation with recombinant alpha 2u-globulin. VNO membrane preparations from female rats were stimulated with 1 µM recombinant alpha 2u-globulin; and subsequently Galpha o (top panel) as well as Galpha i (bottom panel) were precipitated with subtype-specific antibodies (Galpha i, C-10; Galpha o, K-20). The autoradiograms, showing the 40-kDa region of a SDS-PAGE, are representative of three independent experiments with similar results.


    DISCUSSION

In the present study, G protein subtypes involved in urine-induced IP3 formation in VNO preparations were characterized by two different experimental approaches. Subtype-specific G protein antibodies have been used as tools to selectively inhibit urine-induced IP3 responses and to immunoprecipitate G protein subtypes photoaffinity labeled with the hydrolysis resistant GTP analogue [alpha -32P]GTP azidoanilide. The results of both experimental approaches indicate that whole male urine induces activation of Gi as well as Go subtypes, suggesting a role for both G protein subtypes in transducing pheromonal responses mediated by urinary components. Activation of Gi and Go subtypes in the VNO appears to be realized by two structurally different classes of odorants. Whereas Gi activation was only observed upon stimulation with lipophilic, possibly volatile components, Go activation was elicited by alpha 2u-globulin, a major urinary protein, which is a member of the lipocalin superfamily. Previous studies have shown that lipocalin proteins, like alpha 2u-globulin and mouse urinary proteins, share the ability to bind volatile pheromones (34), suggesting that both proteins act as carrier proteins for hydrophobic ligands; however, the results of the present study suggest that alpha 2u-globulin is not merely a carrier of volatile pheromones but is able to induce receptor-mediated Go activation. This observation is in line with previous behavioral studies indicating that members of the lipocalin superfamily may by themselves be active in VNO-mediated pheromonal responses. It has been demonstrated that mouse urinary proteins separated from volatile ligands, either by extraction or competitive displacement, were still active in bioassays (8). Furthermore, recombinant aphrodisin, a lipocalin-like protein from the female golden hamster vaginal discharge, expressed in E. coli induced a specific copulatory response in male golden hamster (35). This observation indicates that lipocalins can act as phermones by themselves. However, a functional role for small ligands cannot be excluded, since recombinant aphrodisin only gained its full activity when it was supplemented with organic extracts of the vaginal discharge (35), suggesting that ligands may modulate the activity of lipocalins by altering its conformation.

A main result of the present study is the observation that both G protein subtypes, activated by different classes of urinary stimuli, led to the activation of phospholipase C and the generation of IP3. Thus, it is the question whether or not there is a physiological significance of having two populations of VNO neurons with distinct activated G protein subtypes that activate the same downstream effector. Activation of phospholipase C by pertussis toxin-sensitive G protein subtypes, like Gi and Go, appears to be mediated by beta gamma -subunits of the trimeric G protein (36). Therefore one might speculate whether the simultaneously released alpha -subunits of Gi and Go may affect pathways not monitored in this study, suggesting a bifunctional action of these G proteins. Galpha o-subunits are well known to modulate the activity of Ca2+ channels (37); thus a Galpha o-regulated channel may contribute to govern the membrane potential in this subset of neurons. In the context of a bifunctional role for Galpha i-subunits, it is interesting to note that vomeronasal neurons express adenylyl cyclase subtype II (13). Galpha i-subunits inhibit AC II (38), thus, it is conceivable that activation of Gi by volatile pheromonal components may not only lead to phospholipase C activation mediated by beta gamma -subunits, but in addition to Galpha i controlled inhibition of AC II. Interestingly, an attenuation of cAMP levels in VNO preparations upon stimulation with the volatile pheromonal components dehydro-exo-brevicomin and 2-(sec-butyl)-4.5-dihydrothiazole has recently been reported (39).

The stereotypical coexpression pattern of the two families of candidate pheromone receptors (14-17) with either Gi or Go implies a functional linkage between both signal transduction elements. Based on characteristic structural features of each receptor family, it has been suggested that the two receptor classes may recognize structurally different chemical stimuli (40). One could imagine that V1Rs, characterized by short N-terminal domain and interconnecting loops, like ORs (14), detect low molecular weight volatiles, whereas V2Rs, having an extremely large highly variable N-terminal domain, may recognize high molecular weight nonvolatile pheromones. Alternatively, as V2Rs-related G protein-coupled receptors, like metabotrophic glutamate receptors (41) and the extracellular calcium sensing receptors (42) recognize very small ligands by means of the large N-terminal domain (43), it appears conceivable that V2Rs may bind small pheromonal components via a "venus flytrap" mechanism as suggested for the metabotrophic glutamate receptors, whereas V1Rs, resembling ORs in the olfactory epithelium, may recognize volatile odorants presented by members of the lipocalin family, e.g. odorant-binding proteins (44). The result of the present study demonstrating that Gi coexpressed with V1Rs is activated by volatile ligands, whereas Go, coexpressed with V2Rs is activated upon stimulation with the protein pheromone alpha 2u-globulin, provide the first experimental evidence that each of the two VNO-receptor families is indeed activated by a distinct class of ligands. The emerging concept that V1Rs are activated by small volatile compounds, whereas V2Rs are specialized for interacting with protein pheromones can now be tested in experimental studies analyzing heterologously expressed receptors.

    ACKNOWLEDGEMENTS

We thank Kerstin Bach for excellent technical assistance and Jörg Strotmann for helpful discussions and critical reading of the manuscript.

    FOOTNOTES

* This work was supported by the Deutsche Forschungsgemeinschaft, the Human Frontier Science Program, European Community project ERBBIO 4 CT 960593, and the Fonds der Chemischen Industrie.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: University Stuttgart-Hohenheim, Institute of Physiology, 70593 Stuttgart, Germany. Fax: 0711-459-3726; Tel.: 0711-459-2274; E-mail: boekhoff{at}uni-hohenheim.de.

    ABBREVIATIONS

The abbreviations used are: OE, olfactory epithelium; VNO, vomeronasal organ; IP3, inositol 1,3,4-trisphosphate; PAGE, polyacrylamide gel electrophoresis; Mops, 4-morpholinepropanesulfonic acid; GTPgamma S, guanosine 5'-O-(thiotriphosphate).

    REFERENCES
Top
Abstract
Introduction
References
  1. Keverne, E. B. (1983) Trends Neurosci. 6, 381-384[CrossRef]
  2. Halpern, M. (1987) Annu. Rev. Neurosci. 10, 325-362[CrossRef][Medline] [Order article via Infotrieve]
  3. Wysocki, C. J., and Meredith, M. (1991) in Neurobiology of Taste and Smell (Finger, T. E., and Silver, W. L., eds), pp. 125-150, John Wiley & Sons, New York
  4. Novotny, M., Harvey, S., Jemiolo, B., and Alberts, J. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 2059-2061[Abstract]
  5. Vandenbergh, J. G., Whitsett, J. M., and Lombardi, J. R. (1975) J. Reprod. Fertil. 43, 515-523[Abstract]
  6. Clissold, P. M., Hainey, S., and Bishop, J. O. (1984) Biochem. Genet. 22, 379-387[Medline] [Order article via Infotrieve]
  7. Clark, A. J., Charal, P., Bingham, R. W., Barrett, D., and Bishop, J. O. (1985) EMBO J. 4, 3159-3165[Abstract]
  8. Mucignat-Caretta, C., Caretta, A., and Cavaggioni, A. (1995) J. Physiol. 486, 517-522[Abstract]
  9. Dihn, B. L., Tremblay, A., and Dufour, D. (1965) J. Immunol. 95, 774-582
  10. Flower, D. R. (1996) Biochem. J. 318, 1-14[Medline] [Order article via Infotrieve]
  11. Böcskei, Z., Groom, C. R., Flower, D. R., Wright, C. E., Phillips, S. E. V., Cavaggioni, A., Findlay, J. B. C., and North, A. C. T. (1992) Nature 360, 186-188[CrossRef][Medline] [Order article via Infotrieve]
  12. Berghard, A., Buck, L. B., and Liman, E. R. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 2365-2369[Abstract/Free Full Text]
  13. Berghard, A., and Buck, L. B. (1996) J. Neurosci. 16, 909-918[Abstract]
  14. Dulac, C., and Axel, R. (1995) Cell 83, 195-206[Medline] [Order article via Infotrieve]
  15. Herrada, G,., and Dulac, C. (1997) Cell 90, 763-773[Medline] [Order article via Infotrieve]
  16. Matsumami, H., and Buck, L. B. (1997) Cell 90, 775-784[Medline] [Order article via Infotrieve]
  17. Ryba, N. J. P., and Tirindelli, R. (1997) Neuron 19, 371-379[Medline] [Order article via Infotrieve]
  18. Halpern, M., Shapiro, L. S., and Jia, C. (1995) Brain Res. 677, 157-161[CrossRef][Medline] [Order article via Infotrieve]
  19. Löbel, D., Marchese, S., Krieger, J., and Breer, H. (1998) Eur. J. Biochem. 254, 318-324[Abstract]
  20. Laugwitz, K.-L., Spicher, K., Schultz, G., and Offermanns, S. (1994) Methods Enzymol. 237, 283-294[Medline] [Order article via Infotrieve]
  21. Holmquist, L., Agrup, G., Anundi, H., and Vesterberg, O. (1989) J. Biochim. Biophys. Methods 20, 303-316
  22. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
  23. Kroner, C., Breer, H., Singer, A. G., and O`Connell, J. (1996) Neuroreport 7, 2989-2992[Medline] [Order article via Infotrieve]
  24. Schandar, M., Laugwitz, K.-L., Boekhoff, I., Kroner, C., Gudermann, T., Schultz, G., and Breer, H. (1998) J. Biol. Chem. 273, 16669-16677[Abstract/Free Full Text]
  25. Pershadsingh, H. A., and McDonald, J. M. (1980) J. Biol. Chem. 255, 4087-4093[Free Full Text]
  26. Palmer, S., Hughes, K. T., Lee, D. Y., and Wakelma, M. J. O. (1989) Cell. Signalling 1, 147-156[CrossRef][Medline] [Order article via Infotrieve]
  27. Offermanns, S., Schultz, G., and Rosenthal, W. (1991) Methods Enzymol. 195, 268-301
  28. Inamura, K., Kashiwayanagi, M., and Kurihara, K. (1997) Chem. Senses 22, 93-103[Abstract]
  29. Menco, B., Tekula, F. D., Farbman, A. I., and Danho, W. (1994) J. Neurocytol. 23, 708-727[Medline] [Order article via Infotrieve]
  30. Wekesa, K. S., and Anholt, R. R. H. (1997) Endocrinology 138, 3497-3506[Abstract/Free Full Text]
  31. Gutowski, S., Smrcka, A., Nowak, L., Wu, D., Simon, M., and Sternweis, P. C. (1991) J. Biol. Chem. 266, 20519-20524[Abstract/Free Full Text]
  32. Menzies, R-A., Heth, G., Ikan, R., Weinstein, V., and Nevo, E. (1992) Physiol. & Behav. 52, 741-747[Medline] [Order article via Infotrieve]
  33. Shoji, T., and Kurihara, K. (1991) J. Gen. Physiol. 98, 909-919[Abstract]
  34. Bacchini, A., Gaetani, E., and Cavaggioni, A. (1982) Experientia 48, 419-421
  35. Singer, A. G., and Macrides, F. (1990) Chem. Senses 15, 199-203
  36. Rhee, S. G., and Bae, Y. S. (1997) J. Biol. Chem. 272, 15045-15048[Free Full Text]
  37. Kleuss, C., Heschler, J., Ewel, C., Rosenthal, W., Schultz, G., and Wittig, B. (1991) Nature 353, 43-48[CrossRef][Medline] [Order article via Infotrieve]
  38. Chen, J., and Iyengar, R. (1993) J. Biol. Chem. 268, 12253-12256[Abstract/Free Full Text]
  39. Zhou, A., and Moss, R. L. (1997) Neuroreport 8, 2173-2177[Medline] [Order article via Infotrieve]
  40. Bargmann, C. I. (1997) Cell 90, 585-587[CrossRef][Medline] [Order article via Infotrieve]
  41. Nakanishi, S. (1992) Science 258, 597-603[Medline] [Order article via Infotrieve]
  42. Brown, E. M., Gamba, G., Riccardi, D., Lombardi, M., Butter, R., Kifor, O., Sun, A., Hediger, M. A., Lytton, J., and Hebert, S. C. (1993) Nature 366, 575-580[CrossRef][Medline] [Order article via Infotrieve]
  43. O`Hara, P. J., Sheppard, H. T., Venezia, D., Haldeman, B., McGrane, V., Houamed, K. M., Thomsen, C., Gilbert, T. L., and Mulvihill, E. R. (1993) Neuron 11, 41-52[Medline] [Order article via Infotrieve]
  44. Pelosi, P. (1994) Crit. Rev. Biochem. Mol. Biol. 29, 199-228[Abstract]
  45. Laugwitz, K-L., Offermanns, S., Spicher, K., and Schultz, G. (1993) Neuron 10, 233[Medline] [Order article via Infotrieve]
  46. Offermanns, S., Laugwitz, K.-L., Spicher, K., Sternweis, C., and Schultz, G. (1994) Proc. Natl. Acad. Sci. U. S. A. 90, 504


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.